Lumican and decorin are differentially expressed in human breast carcinoma

Journal of Pathology

Volumn 192, Issue 3, 2000, Pages 313-320

  Leygue, Etienne ^a   Snell, Linda ^a   Dotzlaw, Helmut ^a   Troup, Sandra ^a   Hiller Hitchcock, Tamara ^a   Murphy, Leigh C ^a   Roughley, Peter J ^b   Watson, Peter H ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; Decorin; Lumican; Small leucine rich proteoglycan; Tumour progression

Indexed keywords

BIGLYCAN; DECORIN; FIBROMODULIN; GENE PRODUCT; LAMICAN; MESSENGER RNA; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CLINICAL ARTICLE; FIBROBLAST; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR GROWTH; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; PROTEOGLYCANS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0033645514     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(200011)192:3<313::AID-PATH694>3.0.CO;2-B     Document Type: Article

References (34)

1. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma
2. Landscaping the cancer terrain
3. Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue
4. Discrimination of fibroblast subtypes by multivariate analysis of gene expression
5. Expression of lumican in human breast carcinoma
6. The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth
7. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases
8. Lumican regulates collagen fibril assembly: Skin fragility and corneal opacity in the absence of lumican
9. Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples
10. The NCIC-Manitoba Breast Tumor Bank: A resource for applied cancer research
11. Microdissection RT-PCR analysis of gene expression in pathologically defined frozen tissue sections
12. The human lumican gene. Organization, chromosomal location, and expression in articular cartilage
13. Changes with age in the structure of fibromodulin in human articular cartilage
14. Non-proteoglycan forms of biglycan increase with age in human articular cartilage
15. Human decorin gene: Intron-exon junctions and chromosomal localization
16. Leucine-rich repeat glycoproteins of the extracellular matrix
17. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility
18. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor
19. Characterization and expression of the mouse lumican gene
20. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer
21. Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan
22. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells
23. Molecular polymorphism of lumican during corneal development
24. Characterization of collagens and proteoglycans at he insertion of the human Achilles tendon
25. Differences in decorin and biglycan expression in patients with gastric ulcer healing
26. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues
27. Selective expression and processing of biglycan during migration of bovine aortic endothelial cells. The role of endogenous basic fibroblast growth factor
28. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels
29. Altered immunohistochemical expression of small proteoglycans in the tumor tissue and stroma of basal cell carcinoma
30. Altered proteoglycan gene expression and the tumor stroma
31. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast
32. Loss of heterozygosity in normal tissue adjacent to breast carcinomas
33. Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican
34. Expression of small extracellular chondroitin/dermatan sulfate proteoglycans is differentially regulated in human endothelial cells